Log In
Print
BCIQ
Print
Print this Print this
 

VBY-891

  Manage Alerts
Collapse Summary General Information
Company Virobay Inc.
DescriptionOral cathepsin S inhibitor
Molecular Target Cathepsin S
Mechanism of ActionCathepsin S inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationPsoriasis
Indication DetailsTreat psoriasis
Regulatory Designation
Partner Leo Pharma A/S

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today